The inhibition of NLRP3 by QZTB, evidenced by the decreased mRNA and protein expressions of NLRP3 in the ankle joint, and the lower production of serum IL-1β and TNF-α level, further indicates the efficacy of QZTB on gouty arthritis in clinic. This evidence concerns the gene NLRP3 and gout.